Our results indicated significantly lower serum values of PAPP-A, PlGF, and PP-13 for patients who later developed preeclampsia and/or IUGR in comparison with the control group, and are in line with the current literature data [34,35]. Here, PAPPA is linked to fetal growth restriction.